Thiobarbituric acid reactive substances and vitamin E in serum and cerebrospinal fluid from patients with cerebral apoplexy. 1982

T Yoshikawa, and K Yamaguchi, and M Kondo, and N Mizukawa, and T Ohta, and K Hirakawa

Thiobarbituric acid (TBA) reactive substances in serum and cerebrospinal fluid from patients with cerebral apoplexy were determined and their relationship to this disease was studied. TBA reactants in serum were elevated in patients with cerebral apoplexy, but there was no difference between patients with brain tumor or other neurological disease and healthy persons. TBA reactants in cerebrospinal fluid in patients with cerebral aneurysm, cerebral arterial and venous anomalies or intracerebral hematoma, and its levels in patients with cerebral infarction or brain tumor were also higher than in healthy persons. Serum alpha-tocopherol levels were elevated in patients with cerebral infarction, but were relatively low in patients with cerebral aneurysm, cerebral arterial and venous anomalies or intracerebral hematoma. The reverse was the case with cerebrospinal fluid levels of alpha-tocopherol. That is, the sequence of decreasing level of alpha-tocopherol in cerebrospinal fluid was intracerebral hematoma, cerebral aneurysm, cerebral arterial and venous anomalies, and cerebral infarction. The levels of TBA reactive substances in patients with cerebral apoplexy showed a positive correlation between serum and cerebrospinal fluid, and the levels of alpha-tocopherol showed a similar correlation.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002561 Cerebrovascular Disorders A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others. Brain Vascular Disorders,Intracranial Vascular Disorders,Vascular Diseases, Intracranial,Cerebrovascular Diseases,Cerebrovascular Insufficiency,Cerebrovascular Occlusion,Brain Vascular Disorder,Cerebrovascular Disease,Cerebrovascular Disorder,Cerebrovascular Insufficiencies,Cerebrovascular Occlusions,Disease, Cerebrovascular,Diseases, Cerebrovascular,Insufficiencies, Cerebrovascular,Insufficiency, Cerebrovascular,Intracranial Vascular Disease,Intracranial Vascular Diseases,Intracranial Vascular Disorder,Occlusion, Cerebrovascular,Occlusions, Cerebrovascular,Vascular Disease, Intracranial,Vascular Disorder, Brain,Vascular Disorder, Intracranial,Vascular Disorders, Brain,Vascular Disorders, Intracranial
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013858 Thiobarbiturates Compounds in which one or more of the ketone groups on the pyrimidine ring of barbituric acid are replaced by thione groups.
D014810 Vitamin E A generic descriptor for all TOCOPHEROLS and TOCOTRIENOLS that exhibit ALPHA-TOCOPHEROL activity. By virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus, these compounds exhibit varying degree of antioxidant activity, depending on the site and number of methyl groups and the type of ISOPRENOIDS.

Related Publications

T Yoshikawa, and K Yamaguchi, and M Kondo, and N Mizukawa, and T Ohta, and K Hirakawa
July 2005, Schizophrenia research,
T Yoshikawa, and K Yamaguchi, and M Kondo, and N Mizukawa, and T Ohta, and K Hirakawa
November 1983, Critical care medicine,
T Yoshikawa, and K Yamaguchi, and M Kondo, and N Mizukawa, and T Ohta, and K Hirakawa
June 1999, Clinical otolaryngology and allied sciences,
T Yoshikawa, and K Yamaguchi, and M Kondo, and N Mizukawa, and T Ohta, and K Hirakawa
January 1998, Revista do Hospital das Clinicas,
T Yoshikawa, and K Yamaguchi, and M Kondo, and N Mizukawa, and T Ohta, and K Hirakawa
October 1989, Lipids,
T Yoshikawa, and K Yamaguchi, and M Kondo, and N Mizukawa, and T Ohta, and K Hirakawa
May 2014, Animal science journal = Nihon chikusan Gakkaiho,
T Yoshikawa, and K Yamaguchi, and M Kondo, and N Mizukawa, and T Ohta, and K Hirakawa
October 1989, Clinical chemistry,
T Yoshikawa, and K Yamaguchi, and M Kondo, and N Mizukawa, and T Ohta, and K Hirakawa
May 1995, The American journal of medicine,
T Yoshikawa, and K Yamaguchi, and M Kondo, and N Mizukawa, and T Ohta, and K Hirakawa
March 2008, Neuroscience letters,
T Yoshikawa, and K Yamaguchi, and M Kondo, and N Mizukawa, and T Ohta, and K Hirakawa
October 2021, Domestic animal endocrinology,
Copied contents to your clipboard!